While certain health conditions like allergies are discussed a lot in public, others like overactive bladder don’t come up a lot in day-to-day life. That can make you feel like you’re the only one ...
Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...
Researchers have developed an ultra-soft and highly stretchable tissue-adhesive hydrogel-based multifunctional implantable sensor for monitoring of overactive bladder. Modern living seems to have ...
Overactive bladder, or OAB, is a condition that causes a sudden urge to urinate. It affects both men and women. The urge may be difficult to stop, and overactive bladder may lead to the involuntary ...
Do you often feel a sudden, intense urge to urinate that disrupts your daily life? If so, you may be experiencing one of the most common overactive bladder symptoms. Understanding the signs to look ...
A marketing authorization should be given for the medicinal product Obgemsa (vibegron) for treating adults with overactive bladder (OAB) syndrome, the European Medicines Agency (EMA) has said. OAB ...
Certain healthcare conditions often go unspoken, leading to silent struggles that affect the lives of many. Overactive bladder (OAB) and fecal incontinence (FI) are two such conditions, impacting ...
Please provide your email address to receive an email when new articles are posted on . Patients with overactive bladder had an odds ratio of 1.4 for osteoarthritis. Overactive bladder was not ...
Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. Led by ...
Greater adherence to the Mediterranean diet is associated with reduced prevalence of overactive bladder (OAB), according to a ...
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results